80th Annual Workers’ Compensation Educational Conference and 37th Safety & Health Conference (WCI 2026)

Event Details

Start: August 23, 2026 @ 11:00AM EDT On-Demand End: August 26, 2026 @ EDT On-Demand Booth Number: 807 Location: Orlando World Center, Marriott 8701 World Center Dr, Orlando, FL 32821

Enlyte returns as an Elite Sponsor at WCI 2026 in Orlando—the nation's leading workers' compensation event.

Visit booth #807 to explore Enlyte's integrated solutions and latest innovations driving better outcomes across the claims journey. We're also hosting an exclusive luncheon on two consecutive days during the conference. To secure your spot at this invitation-only gathering, please contact your Enlyte representative.

We look forward to connecting with you at WCI 2026!

Learn More

More stories

Workers' Comp Article

Implications of Epidiolex FDA Approval on Workers' Compensation

September 5, 2018

Learn how the recent FDA approval of Epidiolex might impact the future of pain management in workers' compensation. In June 2018, the Fed

Workers' Comp Blog

How Differences in Claim Age and Population Affect Opioid Trends

September 2, 2018

Management of opioid therapy can be influenced by the types of drugs filled, differing patient populations, and the nature of the injury.

Mitchell News Release

Illinois Piloting Opioid Alternative Cannabis Program

August 31, 2018

On August 28, 2018, Illinois Governor Bruce Rauner signed into law SB336, the Alternatives to Opioids Act of 2018.

Workers' Comp News Release

Vermont Department of Labor Proposes Rule Incorporating Opioid Prescribing Guidelines

August 29, 2018

By Brian Allen, VP of Government Affairs

Mitchell News Release

Vermont Department of Labor Proposes Rule Incorporating Opioid Prescribing Guidelines

August 29, 2018

The Vermont Department of Labor has proposed a rule that would, by reference, incorporate the Department of Health opioid prescribing guidelines fo

Workers' Comp Blog

Positive Compound Trends Continue in Work Comp

August 26, 2018

Utilization and costs associated with compound medications fell significantly for both managed and unmanaged claims in 2017.